NUVB
Nuvation Bio
$6.28
−$0.24 (−3.68%)Sep 10, 2026
Key metrics
The numbers that frame NUVB today
- Market cap
- $2.21B
- P/E (TTM)
- -14.7
- EV / FCF
- -19.5
- Gross margin
- 88.2%
- EV / Sales
- 13.9
- ROIC
- -19%
- Div yield
- 0%
- Debt / equity
- 1.6
- 52wk Low
- $2.99
- 52wk High
- $9.75
Growth
Revenue and earnings trend for NUVB
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about NUVB
Is Nuvation Bio a good buy?
Hold. Nuvation Bio has excellent momentum, but poor quality makes the setup mixed. Growth looks poor. That could put pressure on the long-term business case. We think Nuvation Bio is selling at a high price.
What is the market capitalization of NUVB?
Nuvation Bio's market capitalization is $2.21B.
What is the P/E ratio for NUVB stock?
Nuvation Bio's current P/E ratio is -14.7.
What is the 52-week high for NUVB stock?
The 52-week high for Nuvation Bio is $9.75. The current close of $6.28 is 35.6% below that high.
What is the 52-week low for NUVB stock?
The 52-week low for Nuvation Bio is $2.99. The current close of $6.28 is 110% above that low.
Does NUVB stock pay dividends?
Nuvation Bio does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for NUVB?
Nuvation Bio's Debt / Equity ratio is 1.64.